ArcelorMittal Reports Third Quarter 2026 Results
ArcelorMittal announced its third-quarter 2026 financial results, reporting $16.5 billion in revenue and $2.02 billion in EBITDA.
Stocks · News reference
This PG&E Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. BMO Capital
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Goldman Sachs Adjusts Edison International Price Target to $69 From $67
Goldman Sachs has updated its price target for Edison International, raising it to $69 from the previous level of $67.
ArcelorMittal Announces Share Transaction Notification by Significant Shareholder
ArcelorMittal has released a regulatory notification regarding share transactions conducted by Lumen Investments S.à r.l., an entity within its significant shareholder structure.
State Farm Joins Coalition Investing in EMBERPOINT Technology
State Farm has joined a cross-industry coalition including PG&E Corporation to invest in EMBERPOINT, a technology platform designed to provide actionable intelligence for firefighters and emergency responders.
Nuvectis Pharma Reports Third Quarter 2026 Financial Results
Nuvectis Pharma reported a net loss of $30.1 million for the third quarter of 2026 and announced the in-licensing of ex-China rights for two drug candidates.
8-K filing — Nuvectis Pharma, Inc. (NVCT)
Filed: 2026-11-04 AccNo: 0001104659-26-122360 Size: 326 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits